Probio Inc.
Pennington, NJ Genscript Probio USA Inc.
- UEI
- GZHYAK6ABHW7
- CAGE
- 9BQX1
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Physical address
- ProBio Inc, Hopewell Facility, 311 Pennington Rocky Hill Rd Building 9, Pennington, NJ 08534, USA
- Website
- genscriptprobio.com
- Founded
- 2002
- Employees
- 251-1K
- Estimated annual revenue
- $100M-$250M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $0 |
| FY2025 | $0 |
| FY2024 | -$14,743 |
Contract awards
Contract subawards
| Prime contractor | Prime award | Amount | Awarded |
|---|---|---|---|
| Mriglobal | 75N91023D00010 | $82,000 | |
| Canon U.s.a., Inc. | 75N91024F00002 | $1,343,550 |
Similar vendors
About the company
Genscript Probio USA Inc. is a corporate entity registered in SAM.gov as a self-certified small disadvantaged business and for-profit organization located in Piscataway, New Jersey. The company appears to specialize in biotechnology and scientific research services, with a focus on advanced biological research techniques such as gene synthesis, antibody production, and related scientific testing. While specific details about the company's full corporate background are not provided, the vendor's federal contract registration indicates a professional orientation toward specialized scientific and research-oriented services for federal agencies.
The company has secured federal contract awards from multiple National Institutes of Health agencies, specifically the National Institute of Diabetes and Digestive and Kidney Diseases and the National Institute of Allergy and Infectious Diseases. Its contract work has included specific projects like economy gene synthesis and antibody production, purification, and testing services. The federal contract awards have been structured as purchase orders, with one notable sub-contract award from Mriglobal involving production of a primary cell bank and plasmid DNA drug substance scheduled for November 2024. The contract awards demonstrate Genscript Probio USA Inc.'s capability to perform complex scientific research and development services for federal agencies, with contract values ranging up to $35,088.00, and no specific set-aside designations applied to the awards.
Quick answers
Is Probio Inc. registered in SAM.gov?
Yes. Probio Inc.'s SAM.gov registration is active through March 27, 2027.
What is Probio Inc.'s most recent federal award?
Probio Inc.'s most recent federal contract award is Nichd - economy gene synthesis (75N94022P00594), from National Institute of Child Health and Human Development (NIH), on August 7, 2022.
On GovTribe
See Probio Inc.'s full federal record
- Federal contract awards
- Subcontracting relationships
- Funding analysis by agency, NAICS and set-aside
- Similar vendors